In prostate cancer, acyl-CoA synthetase medium chain family member 1 and 3 (ACSM1 and ACSM3) regulate lipidome and promotes resistance to ferroptosis through fatty acid oxidation[137]. This evidence concerns the gene ACSM1 and prostate carcinoma.